Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation

So-Ryoung Lee; Eue-Keun Choi; Sang Hyun Park; Jin‐Hyung Jung; Kyungdo Han; Seil Oh; Professor Gregory Lip

doi:10.1161/strokeaha.120.033338

Back

Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation

Article 2021 en

Abstract

1 min read

In this large Asian population with atrial fibrillation, DOAC showed a comparable risk of dementia with warfarin overall. DOACs appeared more beneficial than warfarin, in those aged 65 to 74 years or with a history of stroke. For specific DOACs, only edoxaban was associated with a lower risk of dementia than warfarin.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2020

Comparison between non-vitamin K antagonist oral anticoagulants versus warfarin for the risk of dementia in Asian patients with non-valvular atrial fibrillation

S.R Lee, E K Choi, Sunyoung Park, Kyungdo Han, Seil Oh, Professor Gregory Lip

Article2023

Dementia Risk of Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation

Khi Yung Fong, Yiong Huak Chan, Yue Wang, Colin Yeo, Barbara Helen Rosario, Professor Gregory Lip, Vern Hsen Tan

Preprint2023

Cardiorenal Outcomes of Treatment with Direct Oral Anticoagulants and Warfarin in Patients with Atrial Fibrillation

Yuting Wang, Jo-Hsin Chen, Shu-Fen Liao, Yu-Jen Chen, Professor Gregory Lip, Jong-Shiuan Yeh

Article2019

P4789Comparisons of direct oral anticoagulants and warfarin in patients with atrial fibrillation and liver cirrhosis

Tze‐Fan Chao, Professor Gregory Lip, S A Chen

Article2019

Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity‐Weighted Cohort Study

Mette Søgaard, Flemming Skjøth, Martin Jensen, Jette Nordstrøm Kjældgaard, Professor Gregory Lip, Torben Bjerregaard Larsen, Peter Brønnum Nielsen